Spots Global Cancer Trial Database for The Performance of Patient Support Program in Early Stage Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The Performance of Patient Support Program in Early Stage Breast Cancer
Official Title: A Prospective, Multicentre, Controlled, Observational Study to Evaluate the Performance of Patient Support Programme (PSP) in Improving Patient Adherence With Adjuvant Aromatase Inhibitors (AI) Medication for Postmenopausal, Early Stage Breast Cancer
Study ID: NCT00769080
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to compare the 1-year adherence to upfront adjuvant AI for postmenopausal, early stage breast cancer in the two observational arms; Standard Treatment and Standard Treatment plus PSP arm after one year
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Research Site, Beijing, Beijing, China
Research Site, Chongqing, Chongqing, China
Research Site, Guangzhou, Guangdong, China
Research Site, Nanning, Guangxi, China
Research Site, Harbin, Heilongjiang, China
Research Site, Wuhan, Hubei, China
Research Site, Changsha, Hunan, China
Research Site, Nanjing, Jiangsu, China
Research Site, Qingdao, Shandong, China
Research Site, Shanghai, Shanghai, China
Research Site, Chengdu, Sichuan, China
Research Site, Tianjin, Tianjin, China
Research Site, Hangzhou, Zhejiang, China
Contact Details
Name: Karen Atkin
Affiliation: AstraZeneca
Role: STUDY_DIRECTOR
Name: Emily Huang
Affiliation: AstraZeneca
Role: STUDY_CHAIR
Name: Shen Zhenzhou, Prof
Affiliation: Fudan University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
